Ketogenic Diet and Epilepsy: What We Know So Far
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms, clinical applicability, and dietary variants without systematic review methodology
OpenAlex W2912654638 · doi:10.3389/fnins.2019.00005
What was done
This narrative review synthesizes evidence on the ketogenic diet and its variants (Modified Atkins Diet, Low Glycemic Index Diet) for intractable epilepsy, discussing mechanisms of action, clinical applicability, side effects, and efficacy across pediatric and adult populations.
What was found
The abstract reports no numerical outcome data. It notes that the traditional ketogenic diet has a 90% fat content with low protein and carbohydrates, and concludes that customized ketogenic diets and less-restrictive variants provide treatment alternatives for non-surgical pharmacoresistant epilepsy patients of any age.
Why it matters
It outlines how modifying dietary restrictions into more palatable regimens can help tailor non-pharmacological management for adolescents and adults with drug-resistant epilepsy.
Limits
The abstract describes a narrative overview rather than a systematic review or meta-analysis, provides no quantitative efficacy metrics or participant numbers, and does not report search methodology.
Cited by
- supports In 1921, Dr. Russell Wilder first introduced the ketogenic diet to manage epileptic seizures after observing that fasting reduced seizures.